Market Access News | pharmaphorum

News

J&J gets FDA okay for psoriasis drug icotrokinra

Johnson & Johnson's much-anticipated oral IL-23 drug, icotrokinra, has claimed FDA approval as Icotyde for first-line treatment of plaque psoriasis.

News

First MHRA/NICE aligned guidance due in June

The aligned regulatory pathway for UK drugs regulator MHRA and reimbursement authority NICE gets underway on 1st April.

News

US judge rules Kennedy's vaccine changes 'unlawful'

A US judge has stymied attempts by HHS Secretary Kennedy to change immunisation policy, stopping this week's vaccine advisory panel from going ahead.

News

AZ piles pressure on MSD et al in gastric cancer

AstraZeneca's cancer immunotherapy Imfinzi has been approved in the EU for use before and after surgery for early-stage gastric cancer.

News

GSK's RSV shot cleared in US for all adults

GSK is back on level pegging with its rivals in the RSV vaccine category in the US, after getting FDA approval for Arexvy in the 18 to 49 age bracket.

News

NHS cleared to use Astellas' non-hormonal menopause drug

Around half a million women will soon be able to access Astellas' Veoza treatment for symptoms like hot flushes associated with menopause.

J&J gets FDA okay for psoriasis drug icotrokinra

First MHRA/NICE aligned guidance due in June

US judge rules Kennedy's vaccine changes 'unlawful'

AZ piles pressure on MSD et al in gastric cancer

GSK's RSV shot cleared in US for all adults

NHS cleared to use Astellas' non-hormonal menopause drug

Basecamp lifts veil on Trillion Gene Atlas genomics push

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks